Overview

A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the antidepressant effect of adjunctive treatment with Eszopiclone in subjects receiving venlafaxine for the treatment of Major Depressive Disorder (MDD).
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Eszopiclone
Venlafaxine Hydrochloride